Recurrent Solid Neoplasm Recruiting Phase 1 Trials for Temozolomide (DB00853)

IndicationStatusPhase
DBCOND0080814 (Recurrent Solid Neoplasm)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02975882Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid TumorsTreatment